The global organ transplant immunosuppressant drugs market was valued at US$5.1 bn in 2014 and is expected to decline at a CAGR of - (5.0)% from 2015 to 2023, to reach an estimated value of US$3.2 bn in 2023

1. Global Organ Transplant
Immunosuppressant Drugs Market Research
and Development – Trends and Forecast
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-
drugs.html

2. Report Description:
 The global organ transplant immunosuppressant drugs market will decline at a CAGR of -5.0% during the
forecast period from 2015 to 2023. In 2014, the global organ transplant immunosuppressant drugs market was
estimated at US$5.1 bn and by 2023, the market will shrink to a value of US$3.2 bn.
 The global organ transplant immunosuppressant drugs market is restrained by several factors. Factors such as
the high cost of procedure and inadequate insurance coverage are projected to suppress the global organ
transplant immunosuppressant drugs market in the coming few years. In addition to this, the advent of stem
cells and lack of donor organs will also constrain the global organ transplant immunosuppressant drugs market
in the foreseeable future. Nevertheless, the global market for organ transplant immunosuppressant drugs will
benefit from the growing incidence of chronic diseases resulting in organ failure and disabilities.
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

3. By drug class, the global organ transplant immunosuppressant drugs market is divided into steroids, antibodies,
mTOR inhibitors, antiproliferative agents, calcineurin inhibitors. The global organ transplant immunosuppressant
drugs market was led by the calcineurin inhibitors sector in 2014. This sector was estimated at US$2.3 bn in 2014.
The majority of kidney transplant recipients are prescribed tacrolimus to maintain immunosuppressive regimen
due to its higher potency and lower rejection nephrotoxicity as compared to cyclosporine.
Geography-wise, the global organ transplant immunosuppressant drugs market is segmented into Latin America,
Asia Pacific, Europe, North America, and Rest of the World. The WHO states that in 2013, the U.S. was the most
lucrative country for organ transplantation. The North American region leads the global organ transplant
immunosuppressant drugs market due to technological improvements, enhanced surgical techniques, enhanced
immunosuppressive drugs, and rising success rate of organ transfer procedures.
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

4.  Global Organ Transplant Immunosuppressant Drugs, by Drug Class
 Calcineurin Inhibitors
 Tacrolimus
 Cyclosporine
 Antiproliferative Agents
 Mycophenolate Mofetil
 Mycophenolate Sodium
 Azathioprine
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

5.  Global Organ Transplant Immunosuppressant Drugs, by Geography
 North America
 U.S.
 Canada
 Europe
 U.K.
 Germany
 Rest of Europe
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

6. About Transparency
Market Research :
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research,
customized research, and consulting services. TMR’s global and regional market
intelligence coverage includes industries such as pharmaceutical, chemicals and
materials, technology and media, food and beverages, and consumer goods, among
others. Each TMR research report provides clients with a 360-degree view of the
market with statistical forecasts, competitive landscape, detailed segmentation, key
trends, and strategic recommendations.
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

7. Contact Us:
Mr. Sudip S.
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html